Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „studied“
Suchtreffer
Begriffe & Kennungen
Cresemba · 4.5 · (CYP3A4/5 induction) Anticoagulants Dabigatran etexilate Not studied. No isavuconazole dose (P-gp substrate) D
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 induction) Clarithromycin Not studied. No isavuconazole dose (strong CYP3A4/5 inhibitor) Isavuconazo
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 induction) Clarithromycin Not studied. No isavuconazole dose (strong CYP3A4/5 inhibitor) adjustment
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 induction) Efavirenz Not studied. The concomitant administration (CYP3A4/5 moderate inducer Efaviren
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 induction) Efavirenz Not studied. The concomitant administration (CYP3A4/5 moderate inducer Efaviren
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 induction) Etravirine Not studied. The concomitant administration (moderate CYP3A4/5 inducer) Isavuc
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 induction) Etravirine Not studied. The concomitant administration (moderate CYP3A4/5 inducer) Isavuc
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 induction) Nafcillin Not studied. The concomitant administration (moderate CY3A4/5 inducer) Isavucon
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 induction) Nafcillin Not studied. The concomitant administration (moderate CY3A4/5 inducer) Isavucon
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 induction) Opioids Short-acting opiates Not studied. No isavuconazole dose (alfentanyl, fentanyl) Sh
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 induction) Opioids Short-acting opiates Not studied. No isavuconazole dose (alfentanyl, fentanyl) Sh
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 induction) Rifabutin Not studied. The concomitant administration (strong CYP3A4/5 inducer) Isavucona
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 induction) Rifabutin Not studied. The concomitant administration (strong CYP3A4/5 inducer) Isavucona
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 inhibition) Herbal medicines St John’s wort Not studied. The concomitant administration (strong CYP3
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 inhibition) Herbal medicines St John’s wort Not studied. The concomitant administration (strong CYP3
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 inhibition) Other NNRTI (e.g. nevirapine) Not studied. No isavuconazole dose (CYP3A4/5 and 2B6 induc
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 inhibition) Other NNRTI (e.g. nevirapine) Not studied. No isavuconazole dose (CYP3A4/5 and 2B6 induc
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 inhibition) Other protease inhibitors (e.g. Not studied. No isavuconazole dose fosamprenavir) Protea
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 inhibition) Other protease inhibitors (e.g. Not studied. No isavuconazole dose fosamprenavir) Protea
Eintrag öffnenCresemba · 4.5 · (CYP3A4/5 inhibition) Ritonavir (at doses >200 mg Not studied. The concomitant administration every 12 hours)
Eintrag öffnen